GPC5-AS1: A Potential Drug Target and Biomarker (G100873969)
GPC5-AS1: A Potential Drug Target and Biomarker
Glycopharmacoprotein (GPC) is a family of structurally diverse proteins that play a crucial role in various cellular processes, including cell signaling, cytoskeletal organization, and neurotransmission. GPCs are involved in many essential cellular functions and are often implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The GPC5-AS1 protein is a member of the GPC family and has been identified as a potential drug target and biomarker.
GPC5-AS1 is a 21-kDa protein that is expressed in various tissues, including brain, heart, liver, and muscle. It is highly homophilic, meaning that it has similar sequence preferences in different samples, and has a calculated pI of 4.7. GPC5-AS1 is localized to the endoplasmic reticulum (ER) and is predominantly expressed in the cytoplasm. It has been shown to interact with various cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.
GPC5-AS1 has been shown to play a role in various cellular processes, including cell signaling, cytoskeletal organization, and neurotransmission. For example, GPC5-AS1 has been shown to be involved in the regulation of cell adhesion, cell migration, and neurotransmission. It has been shown to interact with various cellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.
GPC5-AS1 has also been shown to be involved in the regulation of cellular apoptosis. GPC5-AS1 has been shown to play a role in the regulation of apoptosis in various cellular contexts, including cancer cells, neuroendocrine cells, and heart muscle cells. It has been shown to interact with various signaling pathways that are involved in apoptosis, including the TGF-β pathway and the PI3K/Akt pathway.
GPC5-AS1 has also been shown to be involved in the regulation of cellular signaling pathways that are involved in cell cycle progression. GPC5-AS1 has been shown to interact with various signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. It has been shown to play a role in the regulation of cell cycle progression, including the G1 phase, the S phase, and the G2 phase.
GPC5-AS1 has also been shown to be involved in the regulation of cellular signaling pathways that are involved in neurotransmission. GPC5-AS1 has been shown to interact with various signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. It has been shown to play a role in the regulation of neurotransmission, including the release of neurotransmitters, the modulation of ion channels, and the regulation of neurotransmitter receptors.
GPC5-AS1 has been shown to be involved in the regulation of cellular signaling pathways that are involved in inflammation. GPC5-AS1 has been shown to interact with various signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. It has been shown to play a role in the regulation of inflammation, including the regulation of immune cell function, the production of pro-inflammatory cytokines, and the regulation of inflammation-related signaling pathways.
Protein Name: GPC5 Antisense RNA 1
The "GPC5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPC5-AS1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83
